Chimmitecan
Chimmitecan is a potent topoisomerase I inhibitor derived from camptothecin. It demonstrates significant antitumor efficacy in both in vitro cellular assays and in vivo animal models, making it a valuable compound for oncology research and anticancer drug development studies.
Product Specifications
CAS Number
185425-25-6
Product Name Alternative
Chimmitecan, (S) -9-Allyl-10-hydroxycamptothecin, 9-Allyl-10-hydroxycamptothecin, topoisomerase I
Field of Research
Molecular Biology
Purity
98.35% (May vary between batches)
Solubility
DMSO:4.05 mg/mL (10.01 mM)
Smiles
C (C) [C@]1 (O) C2=C (C (=O) N3C (=C2) C=4C (C3) =CC=5C (N4) =CC=C (O) C5CC=C) COC1=O
Molecular Formula
C23H20N2O5
Molecular Weight
404.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS710329-01 0.1 mL
Rabbit anti-human eukaryotic translation initiation factor 4E family member 2 polyclonal Antibody
Sign In for Pricing
View Details MBS710329-02 5x 0.1 mL
Rabbit anti-human eukaryotic translation initiation factor 4E family member 2 polyclonal Antibody
Sign In for Pricing
View Details 
M2360-05-Biotin 100 µL
MAP Kinase p44/42, CT (MAPK3/MAPK1, Mitogen-activated Protein Kinase 1, MAP Kinase 1, MAPK 1, Mapk, ERT1, Extracellular Signal-regulated Kinase 2, ERK-2, MAP Kinase Isoform p42, p42-MAPK, Mitogen-activated Protein Kinase 2, MAP Kinase 2, MAPK 2, ERK2, PRKM1 / Mitogen-activated Protein Kinase 3, MAP Kinase 3, MAPK 3, ERT2, Extracellular Signal-regulated Kinase 1, ERK-1, Insulin-stimulated MAP2 Kinase, MAP Kinase Isoform p44, p44-MAPK, Microtubule-associated Protein 2 Kinase, MNK1, p44-ERK1, ERK1, PRKM3) (Biotin) discontinued
Sign In for Pricing
View Details